Recombinant Human MYLK2, N-His

Introduction

Recombinant Human MYLK2, also known as Myosin Light Chain Kinase 2, is a protein that plays a crucial role in the regulation of smooth muscle contraction. It is a member of the myosin light chain kinase family and is encoded by the MYLK2 gene. Recombinant Human MYLK2 is produced through genetic engineering techniques, making it a highly pure and specific protein with a wide range of applications in the field of biomedical research.

Structure of Recombinant Human MYLK2

Recombinant Human MYLK2 is a 59 kDa protein composed of 528 amino acids. It contains a kinase domain at the N-terminus, followed by a calmodulin-binding domain and a coiled-coil region. The C-terminus of the protein contains a leucine zipper motif, which is involved in protein-protein interactions. This unique structure allows Recombinant Human MYLK2 to interact with various signaling molecules and regulate smooth muscle contraction.

Activity of Recombinant Human MYLK2

The primary function of Recombinant Human MYLK2 is to phosphorylate the regulatory light chain of myosin (MLC20), which is essential for smooth muscle contraction. This process is triggered by the binding of calcium ions to the calmodulin-binding domain of MYLK2, which activates its kinase activity. The phosphorylation of MLC20 leads to the activation of myosin, which then binds to actin filaments and generates the force needed for muscle contraction.

In addition to its role in smooth muscle contraction, Recombinant Human MYLK2 has also been implicated in other cellular processes, such as cell migration, cell division, and cell adhesion. It has been shown to interact with various proteins involved in these processes, suggesting a broader role for MYLK2 in cellular functions.

Application of Recombinant Human MYLK2

Recombinant Human MYLK2 has a wide range of applications in biomedical research, particularly in the study of smooth muscle physiology and diseases. Here are some of the specific applications of Recombinant Human MYLK2:

1. Study of smooth muscle contraction

Recombinant Human MYLK2 is a crucial tool for studying the mechanisms of smooth muscle contraction. Its ability to specifically phosphorylate MLC20 allows researchers to investigate the role of MYLK2 in this process and its interactions with other signaling molecules.

2. Drug discovery and development

Abnormalities in MYLK2 activity have been linked to various diseases, such as hypertension, asthma, and atherosclerosis. Recombinant Human MYLK2 can be used to screen potential drugs that target MYLK2 and its associated pathways, leading to the development of new treatments for these diseases.

3. Biomarker for cancer diagnosis

Recent studies have shown that MYLK2 is overexpressed in certain types of cancer, including breast and colon cancer. Recombinant Human MYLK2 can be used as a biomarker to detect the presence of these cancers and monitor their progression.

4. Production of monoclonal antibodies

Recombinant Human MYLK2 can be used as an antigen to produce monoclonal antibodies specific to MYLK2. These antibodies can then be used for various applications, such as protein detection and purification, as well as in diagnostics and therapeutics.

5. Gene therapy

Mutations in the MYLK2 gene have been associated with various diseases, including hypertrophic cardiomyopathy and coronary artery disease. Recombinant Human MYLK2 can be used in gene therapy to replace the defective gene and restore normal MYLK2 function.

Conclusion

In summary, Recombinant Human MYLK2 is a highly specific and versatile protein with a crucial role in smooth muscle physiology. Its unique structure and activity make it an essential tool in various fields of biomedical research, including drug discovery, cancer diagnosis, and